LUCODACIGENE PARVEC

UNII:	MP86U34PJY
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	LUCODACIGENE PARVEC
GSRS Full Record:	MP86U34PJY i

3062982-56-0
Lucodacigene Parvec
lucodacigene parvec [INN]
recombinant, self-complementary non-replicating adeno-associated virus serotype 9 (rAAV9) vector encoding codon-optimised human aspartoacylase (ASPA, ASP, aminoacylase-2, ACY2). The transgene is preceded by a Kozak sequence, with expression under control of a hybrid cytomegalovirus (CMV) enhancer/chicken beta actin promoter (CB6) and terminated by a rabbit β-globin gene polyadenylation signal; flanked by adeno-associated virus 2 (AAV2) inverted terminal repeats (ITRs) (lucodacigene parvec)

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LUCODACIGENE PARVEC

Synonyms and Mappings

Resources